Showing results (1071-1080 of 14,089) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|August 1, 1996
Prognostic significance of c-erB-2 mRNA in ovarian carcinomaB Tanner, E Kreutz, W Weikel, et al.Gynecologic Oncology|August 1, 1996
Lymphoproliferative disorder involving the cervix in a patient being treated with FK-506J A Sunyecz, F V Price, G Trucco, et al.Gynecologic Oncology|August 1, 1996
Adenocarcinoma of the cervix presenting as ovarian cancer: diagnostic considerationsK K Rawlings, K Look, T M UlbrightGynecologic Oncology|August 1, 1996
Endometriosis with myxoid change simulating mucinous adenocarcinoma and pseudomyxoma peritoneiA Hameed, N Jafri, L J Copeland, et al.Gynecologic Oncology|June 1, 1996
Adenocarcinoma in situ of the uterine cervix: management and outcomeT Widrich, A W Kennedy, T M Myers, et al.Gynecologic Oncology|June 1, 1996
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovaryE Reed, G Sarosy, E Kohn, et al.Gynecologic Oncology|June 1, 1996
Metastatic choriocarcinoma in a postmenopausal womanG Massenkeil, G Crombach, S Dominik, et al.Gynecologic Oncology|June 1, 1996
Angiographic-guided embolization of metastatic invasive moleM W Method, M Hirschfield, H E EveretteGynecologic Oncology|March 1, 1997
Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervixS N Bae, S E Namkoong, J K Jung, et al.Gynecologic Oncology|March 1, 1997
Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancerJ T Comerci, A L Fields, C D Runowicz, et al.Pageof 1,409